 comparative study hemaccel albumin infusion total paracentesis cirrhotic patients refractory ascites cirrhotic patients refractory ascites one-session large-volume paracentesis groups first group human albumin second group hemaccel doses comparable oncotic power groups incidence complications recurrence massive ascites hospital dismissal survival rate incidence complications paracentesis probability readmission hospital ascites probability survival entry study groups multivariate analysis parameters treatment modality absolute unresponsiveness diuretics independent predictor mortality results hemaccel infusion albumin infusion total paracentesis cirrhotic patients refractory ascites